Diabetes, Metabolic Syndrome and Obesity

COPE logo
ISSN: 1178-7007

Technology, Treatments and Therapeutics


Section Editor(s):

Dr Halis Kaan Akturk, Medicine and Pediatrics, Barbara Davis Center for Diabetes, University of Colorado, Boulder, CO, USA

This section considers submissions on therapeutic approaches to diabetes, metabolic syndrome and obesity management, with a focus on clinical applications, treatment modalities, and technological advancements in patient care. This includes Continuous Glucose Monitoring (CGM), Automated Insulin Delivery (AID), smart insulin pens, insulin pumps, insulin therapy, oral antidiabetics, injectable diabetes medications and treatments for type 1 and type 2 diabetes in adults. This section emphasizes clinical trials and clinically relevant research that has direct application to patient care and real-world implementation. This section will not consider basic science or pre-clinical research without human clinical data.

Latest articles in Technology, Treatments and Therapeutics:

- 25 records -

Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review

Pizirtzidou E, Karagkounis C, Bellali T, Katsiki N, Kazakos K, Muzurović E, Minasidou E

Diabetes, Metabolic Syndrome and Obesity 2026, 19:598765

Published Date: 12 May 2026

The Diabetes Staging System (DSS): A Pilot Study Assessing Feasibility, Provider Engagement and Implementation Challenges of a Novel Staging System for Type 2 Diabetes

Dar MS, Zhang J, Ashline A, Kota S, Woolson S, Majette NT, Bosworth HB

Diabetes, Metabolic Syndrome and Obesity 2026, 19:556175

Published Date: 9 April 2026

Comparative Association of Basal and Basal-Prandial Insulin Regimens on Remnant Cholesterol and Lipid Profiles in Patients with Type 2 Diabetes Mellitus

Natsir RM, Halimah E, Diantini A, Levita J, Umar H

Diabetes, Metabolic Syndrome and Obesity 2026, 19:588522

Published Date: 12 March 2026

Systematic Review of Oral Carbohydrate Treatment for Non-Severe Hypoglycemia in Type 1 Diabetes: A Comparison of Insulin Management Systems

Prince NL, Lochnan HA, Shorr R, Garon-Mailer A, Sun CJ

Diabetes, Metabolic Syndrome and Obesity 2026, 19:568538

Published Date: 7 March 2026

A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management

Chen Q, Chen T, Lin W, Chen X

Diabetes, Metabolic Syndrome and Obesity 2026, 19:585436

Published Date: 10 February 2026

Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders

Qiao Y, Zhou F, Mao T, Gao L

Diabetes, Metabolic Syndrome and Obesity 2026, 19:559587

Published Date: 10 February 2026

Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

Liu BCL, Hannah KL, Nemlekar PM, Green CR, Norman GJ

Diabetes, Metabolic Syndrome and Obesity 2026, 19:574769

Published Date: 5 February 2026

Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh

Selim S, Rahman MH, Mustari M, Mohiuddin SM, Ahammed A, Hannan MA, Sharifuzzaman M, Mahjabeen S, Saifuddin M, Rahman MM, Afsana F, Raunak AIB

Diabetes, Metabolic Syndrome and Obesity 2026, 19:576436

Published Date: 3 February 2026

GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies

Alourfi NM, Alorfi NM

Diabetes, Metabolic Syndrome and Obesity 2026, 19:584052

Published Date: 3 February 2026

Transition from Continuous Subcutaneous Insulin Infusion to IDeg-Based Regimens in Hospitalized T2DM Patients: A Single-Center Retrospective Analysis

Dong R, Gu L, Li H, Hu Y, Liu H, Kou X, Zhao Y, Zhao M, Shi B, Guo H, Qiang W

Diabetes, Metabolic Syndrome and Obesity 2026, 19:557994

Published Date: 13 January 2026

Systematic Review of Continuous Glucose Monitoring and Its Effect on Quality of Life in Type 2 Diabetes Mellitus

Dwiastuti A, Latarissa IR, Hidayat A, Halimah E, Lestari K

Diabetes, Metabolic Syndrome and Obesity 2026, 19:561759

Published Date: 8 January 2026

Revolutionizing Diabetes Care: From Tech to Therapeutics

Akturk HK, Waterman LA, Cobry EC

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4675-4682

Published Date: 20 December 2025

Impact of SGLT2 Inhibitors on Tumor Development Risk in Type 2 Diabetes: A Retrospective Cohort Study

Wang Y, Ding Y, Yan X, Yao J, Wang M, Li Z, Zhu Y

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4587-4596

Published Date: 15 December 2025

Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study

Sharifuzzaman M, Paul AK, Akteruzzaman M, Bhuiyan SH, Haider R, Sharker S, Sultana D, Alam KM, Abu Zafar S, Kashem MA, Abu Zahid M, Islam AN, Abedin MZ, Anar F, Hasan MF, Selim S, Islam S, Ahammed A, Hosen M, Qureshi NK, Hossain MA, Begum A, Afrooz F, Kobir AM, Akter F, Mustafa SJ, Rahman MM, Saifuddin M

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4465-4482

Published Date: 4 December 2025

Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Mellitus: An Umbrella Review of Systematic Reviews

Shabil M, Kasoj M, Sulthana H, Ullah A, Verma A, Sah R, Mehta R, Babaresh WM

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4423-4437

Published Date: 2 December 2025

Efficacy and Safety of Roflumilast versus Alpha-Lipoic Acid in Type 2 Diabetes with Neuropathy: A Comparative Clinical Study

Elsharab A, Nooh MZ, Matard RS, Mostafa TM, El-Afify DR

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4193-4210

Published Date: 13 November 2025

Advances in Stem Cell Therapy for Diabetic Foot Ulcers

Wang B, Zhao G, Zhang J, Chen W, Yang S, Sun Y

Diabetes, Metabolic Syndrome and Obesity 2025, 18:4021-4034

Published Date: 29 October 2025

Long-Term Efficacy Trajectories of GLP-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis

Li Z, Han Z, Sun R, Xuan X, Huang C

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3611-3624

Published Date: 23 September 2025

Analysis of Predictive Factors for the Efficacy of Modified Three-Port Laparoscopic Sleeve Gastrectomy in Treating Type 2 Diabetes Mellitus

Xu Z, Zhang W, Chen S, Liu B, Sun Y

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3375-3385

Published Date: 9 September 2025

Clinical Outcomes and Complications of Basal, Bolus, and Combination Insulin Regimens in Type 2 Diabetes Mellitus: Evidence from Published Case Reports

Natsir RM, Halimah E, Diantini A, Levita J

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3215-3236

Published Date: 3 September 2025

Effects of Additional Chinese Herbal Medicines Treatment in Patients with Type 2 Diabetes Mellitus Combined with Stable Angina Pectoris: A Retrospective Cohort Study

Xu X, Yin S, Liu H, Zhao R, Cui W, Shao M, Yu H, Yan S, Fu Y

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3135-3148

Published Date: 31 August 2025

Continuous Glucose Monitoring During Recreational Diving in Type 1 Diabetes: Navigating Clinical and Technical Uncertainties

Popovic DS, Koufakis T, Patoulias D, Stoian AP, Papanas N

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3089-3092

Published Date: 27 August 2025

Investigating Real-World Stability and Sterility of in-Use Insulin-An Urgent Public Health Concern. In Sub-Saharan Africa

Youtube play button
Youtube thumbnail

Kimaro E, Konje ET, Mori AT, Kidenya BR, Kaale E

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3027-3030

Published Date: 22 August 2025


Read more articles

Other sections from this journal: